Liver damage from stress and aging might be reversible reveals study
HQ Team July 19, 2024: Researchers at Duke University have gained some new insights into age-related degeneration of liver. In an animal experiment,.
Drugs
Health
Medical
Drugs
Health
Medical
Dementia can be misdiagnosed in some cirrhosis patients
HQ Team July 18, 2024: Researchers at the Virginia Commonwealth University’s School of Medicine and the Richmond VA Medical Center say that almost.
Drugs
Health
Pharma
FDA nod for Gilead to expand hepatitis drug to six years or older patients
HQ Team March 28, 2024: US regulator, the FDA has approved Gilead Sciences, Inc.’s supplemental new drug application for treating chronic hepatitis B.
Drugs
Health
Pharma
Akero Therapeutics says mid-stage trials on drug for fatty liver disease positive
HQ Team March 4, 2024: US-based Akero Therapeutics, Inc., announced its mid-trial of a drug to treat fatty liver disease met its primary.
Drugs
Medical
Pharma
Gilead buys CymaBay for $ 4.3b to expand its liver portfolio
HQ Team February 13, 2024: Gilead Sciences is buying CymaBay Therapeutics for $4.3 billion, to access its portfolio of drugs for liver and.
Drugs
Health
Pharma
Cure for nonalcoholic fatty liver disease may be near: Scientists say
HQ Team April 11, 2023: Scientists are close to developing a human treatment for nonalcoholic fatty liver after successfully developing a compound tested.
Health
Medical
Third vaccine reduces critical response to covid in patients with cirrhosis
Booster shots reduce severity of covid in cirrhosis patients